首页> 美国卫生研究院文献>BMC Medical Genetics >Screening of WT1 mutations in exon 8 and 9 in children with steroid resistant nephrotic syndrome from a single centre and establishment of a rapid screening assay using high-resolution melting analysis in a clinical setting
【2h】

Screening of WT1 mutations in exon 8 and 9 in children with steroid resistant nephrotic syndrome from a single centre and establishment of a rapid screening assay using high-resolution melting analysis in a clinical setting

机译:从一个中心筛查患有类固醇抗性肾病综合征儿童的第8和第9外显子的WT1突变并在临床环境中使用高分辨率熔解分析建立快速筛查方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundMutations in Wilm’s tumor 1 (WT1) gene is one of the commonly reported genetic mutations in children with steroid resistant nephrotic syndrome (SRNS). We report the results of direct sequencing of exons 8 and 9 of WT1 gene in 100 children with SRNS from a single centre. We standardized and validated High Resolution Melt (HRM) as a rapid and cost effective screening step to identify individuals with normal sequence and distinguish it from those with a potential mutation. Since only mutation positive samples identified by HRM will be further processed for sequencing it will help in reducing the sequencing burden and speed up the screening process.
机译:背景威尔姆1号肿瘤(WT1)基因的突变是类固醇抵抗性肾病综合征(SRNS)儿童普遍报道的遗传突变之一。我们报道了来自单个中心的100名SRNS儿童的WT1基因外显子8和9的直接测序结果。我们对高分辨率熔体(HRM)进行了标准化和验证,这是一种快速且经济高效的筛选步骤,可识别具有正常序列的个体并将其与潜在突变的个体区分开。由于仅将HRM鉴定的突变阳性样品进一步处理以进行测序,因此将有助于减少测序负担并加快筛选过程。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号